反应详情

N-(2-t-butoxycarbonylaminophenyl)-4-(4,4,5,5,tetramethyl-1,3,2,-dioxaborolan-2-yl)benzamide (1.2 g, 2.74 mmol; prepared as described in international patent publication number wo03/087057, method 13, page 60), 2-chloro-3-cyano-5-formylpyridine [prepared as described in de 4429465 a1 (1996)] (456 mg, 2.74 mmol), 1,1′-bis(diphenylphosphino)ferrocene-palladium(ii)dichloride dichloromethane complex 112 mg, 0.137 mmol), 1,2-dimethoxyethane (12 ml) and a saturated aqueous solution of sodium hydrogen carbonate (6 ml) were stirred at 60° c. under an atmosphere of nitrogen for 7.5 hours. the mixture was allowed to cool before being partitioned between dichloromethane and water. the organics were separated, dried over sodium sulfate, filtered and evaporated. the crude product was purified by chromatography on silica eluting with 30:70 to 40:60 ethyl acetate: isohexane to afford the title compound as a cream solid (615 mg, 51%); nmr spectrum: (dmso-d6) 1.45 (s, 9h), 7.18 (m, 2h), 7.56 (m, 2h), 8.10 (d, 2h), 8.17 (d, 2h), 8.70 (s, 1h), 8.90 (d, 1h), 9.39 (d, 1h), 9.97 (s, 1h), 10.18 (s, 1h); mass spectrum: m+na+ 465.

1. temperatureto cool
2. custombefore being partitioned between dichloromethane and water
3. customthe organics were separated
4. dry with materialdried over sodium sulfate
5. filtrationfiltered
6. customevaporated
7. customthe crude product was purified by chromatography on silica eluting with 30:70 to 40:60 ethyl acetate